AAAAAA

   
Results: 1-25 | 26-28 |
Results: 26-28/28
Development of copolymer 1 (Copaxone (R)) as a specific drug against multiple sclerosis
Authors: Teitelbaum, D Aharoni, R Fridkis-Hareli, M Arnon, R Sela, M
Citation: D. Teitelbaum et al., Development of copolymer 1 (Copaxone (R)) as a specific drug against multiple sclerosis, DECADE OF AUTOIMMUNITY, 1999, pp. 191-196
The involvement of myasthenogenic T-cell epitopes and their analogs in theclinical manifestations and treatment of myasthenia gravis
Authors: Mozes, E Sela, M
Citation: E. Mozes et M. Sela, The involvement of myasthenogenic T-cell epitopes and their analogs in theclinical manifestations and treatment of myasthenia gravis, DECADE OF AUTOIMMUNITY, 1999, pp. 245-253
Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1
Authors: Aharoni, R Teitelbaum, D Sela, M Arnon, R
Citation: R. Aharoni et al., Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1, J NEUROIMM, 91(1-2), 1998, pp. 135-146
Risultati: 1-25 | 26-28 |